Flavonoid IL-17A inhibitors
US10385034B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2015 |
| Grant date | Aug 20, 2019 |
| Priority date | — |
| Expiry date | Sep 8, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes compounds according to formula I: and compounds according to formula II: and additional related flavonoid compounds, as well as the use of the compounds in methods for the prevention or treatment of IL-17A-mediated disease in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.